Benchmark Upgrades IMAX Corporation (IMAX) to Buy
Benchmark upgraded IMAX Corporation (NYSE: IMAX) from Hold to Buy with a price target of $30.56.Analyst Mike Hickey said ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
